Lishan Aklog - Jan 7, 2022 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Chief Executive Officer, Director
Signature
Lishan Aklog
Stock symbol
LUCD
Transactions as of
Jan 7, 2022
Transactions value $
$0
Form type
4
Date filed
1/10/2022, 07:06 PM
Previous filing
Oct 13, 2021
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUCD Common stock Award $0 +60K +10.63% $0.00 624K Jan 7, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of January 7, 2025. Such restricted stock is subject to forfeiture if the requisite service period is not completed.